Condition: Asthma Intermittent, Uncontrolled · Sponsor: Queen Mary University of London
The goal of this study is to deliver a definitive randomised controlled trial to measure the effectiveness and assess cost-effectiveness of a digital social intervention for patients with asthma, composed of promoting engagement with online peer support in a primary care consultation, followed by engagement with online peer support for 12 months. The main questions/objectives this study aims to answer/address are: * Does promoting engagement with an online health community in primary care help people with troublesome asthma to experience fewer asthma symptoms? * To assess cost-effectiveness of the intervention (including quality of life, well-being, use of healthcare services etc); stakeholder satisfaction (patients and healthcare professionals) with the intervention; fidelity of protocol delivery; context in which positive outcomes can be triggered.
This description comes directly from the study's public registry record.
Anna De Simoni, PhD · +442078822520 · a.desimoni@qmul.ac.uk
Georgios Karampatakis, PhD · g.karampatakis@qmul.ac.uk
Always discuss trial participation with your own doctor first.
| South West Peninsula Regional Research Delivery Network | Exeter, United Kingdom | Not Yet Recruiting |
| East Midlands Regional Research Delivery Network | Leicester, United Kingdom | Recruiting |
| North London Regional Research Delivery Network | London, United Kingdom | Recruiting |
| North East and North Cumbria | Newcastle upon Tyne, United Kingdom | Recruiting |
| East of England Regional Research Delivery Network | Norwich, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06849245